Hyd-based Biophore seeks DCGI approval for use of Aviptadil in COVID treatment
Hyderabad: Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the